CONFERENCE COMMITTEE REP. NO. 39

 

Honolulu, Hawaii

                 , 2015

 

RE:    S.B. No. 1131

       S.D. 2

       H.D. 2

       C.D. 1

 

 

 

Honorable Donna Mercado Kim

President of the Senate

Twenty-Eighth State Legislature

Regular Session of 2015

State of Hawaii

 

Honorable Joseph M. Souki

Speaker, House of Representatives

Twenty-Eighth State Legislature

Regular Session of 2015

State of Hawaii

 

Madam and Sir:

 

     Your Committee on Conference on the disagreeing vote of the Senate to the amendments proposed by the House of Representatives in S.B. No. 1131, S.D. 2, H.D. 2, entitled:

 

"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"

 

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

 

     The purpose of this measure is to:

 

     (1)  Update the Uniform Controlled Substances Act, chapter 329, Hawaii Revised Statutes, for consistency with amendments in federal law on controlled substances;

 

     (2)  Add a new synthetic cathinone and eight new synthetic cannabinoids to section 329-14, Hawaii Revised Statutes;

 

     (3)  Amend section 329-16(b), Hawaii Revised Statutes, to remove certain opium and opiate compounds and their respective salts from the Schedule II narcotic drugs; and

 

     (4)  Amend section 329-20, Hawaii Revised Statutes, to add new controlled substances that have been federally scheduled, as required under section 329-11, Hawaii Revised Statutes.

 

     Your Committee on Conference finds that this measure amends Hawaii's Uniform Controlled Substances Act, codified as chapter 329, Hawaii Revised Statutes, to be consistent with changes in federal law and any emergency scheduling actions taken by the Narcotics Enforcement Division Administrator, as required by section 329-11, Hawaii Revised Statutes.  Your Committee on Conference further finds that there is a growing problem in the State of new synthetic hallucinogenic substances being offered for sale to the public as herbal incense, bath salts, plant food, or legal highs.  Numerous adverse effects have been reported from these new synthetic cathinones and synthetic cannabinoids, including seizures, coma, agitation, convulsions, and, in some cases, death.

 

     Your Committee on Conference has amended this measure by:

 

     (1)  Deleting language removing certain opium and opiate compounds and their respective salts from the Schedule II narcotic drugs;

 

     (2)  Inserting an effective date of upon approval; and

 

     (3)  Making technical, nonsubstantive amendments for the purposes of clarity and consistency.

 

     As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of S.B. No. 1131, S.D. 2, H.D. 2, as amended herein, and recommends that it pass Final Reading in the form attached hereto as S.B. No. 1131, S.D. 2, H.D. 2, C.D. 1.

 


Respectfully submitted on behalf of the managers:

 

ON THE PART OF THE HOUSE

 

ON THE PART OF THE SENATE

 

_________________________________

DELLA AU BELATTI, Co-Chair

 

___________________________________

WILL ESPERO, Chair

_________________________________

JOY A. SAN BUENAVENTURA, Co-Chair

 

___________________________________

GILBERT S.C. KEITH-AGARAN, Co-Chair